Logo
P

Protagonist Therapeutics

134 employees

Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. Our platform enables us to discover peptides in a de novo fashion with the desired degree of potency, specificity and selectivity, and also engineer oral stability with specific peptidomimetic and chemical modifications.

Investor insights

Funding rounds participated in

$132M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology

Sectors

Biotechnology

Date founded

2006

Funding rounds raised

Total raised

$132M

from investors over 1 rounds

P

Protagonist Therapeutics raised $132M on July 14, 2021

FAQ